Experimental COVID-19 vaccine safe, generates immune response
National Institutes of Health (NIH) sent this bulletin at 07/14/2020 05:30 PM EDTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
07/14/2020 05:00 PM EDT
NIH-sponsored Phase 1 trial tested mRNA vaccine.